All Relations between Neuromyelitis Optica and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
Kathryn B Holroyd, Sarah E Conwa. Central Nervous System Neuroimmunologic Complications of COVID-19. Seminars in neurology. 2023-04-20. PMID:37080234. autoimmune disorders of the central nervous system following covid-19 infection include multiple sclerosis (ms), neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune encephalitis, acute disseminated encephalomyelitis, and other less common neuroimmunologic disorders. 2023-04-20 2023-08-14 Not clear
Tetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, Kumi Nakaya, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Fumi Itabashi, Ikumi Kanno, Kimihiko Kaneko, Toshiyuki Takahashi, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima, Atsushi Hozaw. White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease. Scientific reports. vol 13. issue 1. 2023-04-20. PMID:37081126. white blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease. 2023-04-20 2023-08-14 human
Tetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, Kumi Nakaya, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Fumi Itabashi, Ikumi Kanno, Kimihiko Kaneko, Toshiyuki Takahashi, Juichi Fujimori, Yoshiki Takai, Shuhei Nishiyama, Tadashi Ishii, Masashi Aoki, Ichiro Nakashima, Atsushi Hozaw. White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease. Scientific reports. vol 13. issue 1. 2023-04-20. PMID:37081126. white blood cell (wbc) count profiles in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and anti-myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are still unknown. 2023-04-20 2023-08-14 human
Yuki Matsumoto, Kimihiko Kaneko, Toshiyuki Takahashi, Yoshiki Takai, Chihiro Namatame, Hiroshi Kuroda, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain : a journal of neurology. 2023-04-16. PMID:37061817. the spectrum of myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) includes optic neuritis (on), myelitis (my), acute disseminated encephalomyelitis (adem), brainstem encephalitis, cerebral cortical encephalitis (ce), and aquaporin-4-igg (aqp4-igg)-negative neuromyelitis optica spectrum disorder (nmosd). 2023-04-16 2023-08-14 Not clear
Edith L Graha. Neuroimmunological Disorders: The Gender Effect. Neurologic clinics. vol 41. issue 2. 2023-04-08. PMID:37030960. treatments for other neuroimmunologic disorders such as neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, neurosarcoidosis, and central nervous system vasculitis may require rituximab before and prednisone or intravenous immunoglobulin therapy during pregnancy. 2023-04-08 2023-08-14 Not clear
Tianrong Yeo, Rachel Wan En Siew, Muhammad Yaaseen Gulam, Janis Siew Noi Tye, Amelia Yun Yi Aw, Thanushiree Sivalingam, Xuejuan Peng, Kok Pin Yong, Seyed Ehsan Saffari, Yinxia Chao, Kevin Ta. COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore. Journal of neurology. 2023-04-07. PMID:37027019. herein, we investigate the incidence and risk factors for covid-19 infection in vaccinated adult patients with multiple sclerosis (ms), aquaporin-4-antibody neuromyelitis optica spectrum disorder (aqp4-ab nmosd), and myelin oligodendrocyte glycoprotein-antibody associated disease (mogad) during the omicron subvariant ba.1/2 wave in singapore. 2023-04-07 2023-08-14 Not clear
Teri Schreiner, Molly Wilson-Murphy, Jan Mendelt-Tillema, Michael Waltz, Rachel Codden, Leslie Benson, Mark Gorman, Manu Goyal, Lauren Krupp, Tim Lotze, Soe Mar, Jayne Ness, Mary Rensel, Shelly Roalstad, Moses Rodriguez, John Rose, Nikita Shukla, Emmanuelle Waubant, Yolanda Wheeler, T Charles Casper, Tanuja Chitni. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-03-24. PMID:36960480. pediatric patients with multiple sclerosis (poms) and related disorders, clinically isolated syndrome (cis), myelin oligodendrocyte glycoprotein antibody disorder (mogad), and neuromyelitis optica spectrum disorder (nmosd), are commonly treated with immunosuppressants. 2023-03-24 2023-08-14 Not clear
Negar Moheb, John J Che. The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review. Eye (London, England). 2023-03-17. PMID:36928226. however, since the completion of the ontt, there has been the discovery of aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibodies, which are biomarkers for neuromyelitis optica spectrum disorder (nmosd) and mog antibody-associated disease (mogad), respectively. 2023-03-17 2023-08-14 Not clear
Susanna Asseyer, Nasrin Asgari, Jeffrey Bennett, Omer Bialer, Yolanda Blanco, Francesca Bosello, Anna Camos-Carreras, Edgar Carnero Contentti, Sara Carta, John Chen, Claudia Chien, Mashina Chomba, Russell C Dale, Josep Dalmau, Kristina Feldmann, Eoin P Flanagan, Caroline Froment Tilikete, Carolina Garcia-Alfonso, Joachim Havla, Mark Hellmann, Ho Jin Kim, Philipp Klyscz, Frank Konietschke, Chiara La Morgia, Marco Lana-Peixoto, Maria Isabel Leite, Netta Levin, Michael Levy, Sara Llufriu, Pablo Lopez, Itay Lotan, Alessandra Lugaresi, Romain Marignier, Sara Mariotto, Susan P Mollan, Cassandra Ocampo, Frederike Cosima Oertel, Maja Olszewska, Jacqueline Palace, Lekha Pandit, José Luis Peralta Uribe, Sean Pittock, Sudarshini Ramanathan, Natthapon Rattanathamsakul, Albert Saiz, Sara Samadzadeh, Bernardo Sanchez-Dalmau, Deanna Saylor, Michael Scheel, Tanja Schmitz-Hübsch, Jemal Shifa, Sasitorn Siritho, Pia S Sperber, Prem S Subramanian, Alon Tiosano, Adi Vaknin-Dembinsky, Alvaro Jose Mejia Vergara, Adi Wilf-Yarkoni, Luis Alfonso Zarco, Hanna G Zimmermann, Friedemann Paul, Hadas Stiebel-Kalis. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis. Frontiers in neurology. vol 14. 2023-03-13. PMID:36908609. optic neuritis (on) often occurs at the presentation of multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). 2023-03-13 2023-08-14 Not clear
Edgar Carnero Contentti, Pablo A López, Juan Criniti, Juan Pablo Pettinicchi, Edgardo Cristiano, Liliana Patrucco, Elisa Bribiesca Contreras, Enrique Gómez-Figueroa, José Flores-Rivera, Edgar Patricio Correa-Díaz, Ana María Toral Granda, María Angelica Ortiz Yepez, Wilson Alfredo Gualotuña Pachacama, Jefferson Santiago Piedra Andrade, Lorna Galleguillos, Verónica Tkachuk, Débora Nadur, Vanessa Daccach Marques, Ibis Soto de Castillo, Magdalena Casas, Leila Cohen, Ricardo Alonso, Alejandro Caride, Marco Lana-Peixoto, Juan Ignacio Roja. Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America. Multiple sclerosis and related disorders. vol 72. 2023-03-12. PMID:36907119. optic neuritis (on) can be an initial manifestation of neuromyelitis optica spectrum disorder (nmosd) associated with aquaporin 4-antibody (aqp4-ab) or myelin oligodendrocyte glycoprotein antibody (mog-ab)-associated disease (mogad). 2023-03-12 2023-08-14 Not clear
Hiroki Masuda, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Mayumi Muto, Ryohei Ohtani, Reiji Aoki, Satoshi Kuwabar. Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD. Scientific reports. vol 13. issue 1. 2023-03-02. PMID:36864239. patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4 + nmosd) were reported to demonstrate worse outcomes compared with patients with anti-myelin oligodendrocyte glycoprotein-associated disorders (mogad). 2023-03-02 2023-08-14 Not clear
Yanlin Lang, William Robert Kwapong, Lingyao Kong, Ziyan Shi, Xiaofei Wang, Qin Du, Bo Wu, Hongyu Zho. Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study. Frontiers in immunology. vol 14. 2023-02-16. PMID:36793713. retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: an oct/octa study. 2023-02-16 2023-08-14 Not clear
Yanlin Lang, William Robert Kwapong, Lingyao Kong, Ziyan Shi, Xiaofei Wang, Qin Du, Bo Wu, Hongyu Zho. Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study. Frontiers in immunology. vol 14. 2023-02-16. PMID:36793713. to compare the optical coherence tomography (oct)/oct angiography (octa) measures in patients with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad). 2023-02-16 2023-08-14 Not clear
M Etemadifar, M Fereidan-Esfahani, N Sedaghat, P K Kargaran, A R Mansouri, A P Abhari, A Aghababaei, A Jannesari, M Salari, M Ganjalikhani-Hakemi, H Nour. Non-infectious meningitis and CNS demyelinating diseases: A conceptual review. Revue neurologique. 2023-02-13. PMID:36781321. we gathered and tabulated cases of non-infectious, steroid-responsive meningitis or meningoencephalitis associated with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein-associated disease (mogad). 2023-02-13 2023-08-14 Not clear
Sohyeon Kim, Hung Youl Seo. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-02-13. PMID:36781562. vaccination against the coronavirus disease 2019 (covid-19) is recommended for patients with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2023-02-13 2023-08-14 Not clear
Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palac. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet. Neurology. 2023-01-27. PMID:36706773. serum antibodies directed against myelin oligodendrocyte glycoprotein (mog) are found in patients with acquired cns demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder. 2023-01-27 2023-08-14 Not clear
Martin W Hümmert, Franziska Bütow, Daria Tkachenko, Ilya Ayzenberg, Thivya Pakeerathan, Kerstin Hellwig, Luisa Klotz, Vivien Häußler, Jan-Patrick Stellmann, Clemens Warnke, Yasemin Goereci, Thorleif Etgen, Felix Luessi, Paul Bronzlik, Stefan Gingele, Ann-Sophie Lauenstein, Ingo Kleiter, Paulus S Rommer, Friedemann Paul, Judith Bellmann-Strobl, Ankelien Duchow, Florian Then Bergh, Refik Pul, Annette Walter, Hannah Pellkofer, Tania Kümpfel, Mosche Pompsch, Markus Kraemer, Philipp Albrecht, Orhan Aktas, Marius Ringelstein, Makbule Senel, Katrin Giglhuber, Achim Berthele, Sven Jarius, Brigitte Wildemann, Corinna Trebs. Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study. Neurology(R) neuroimmunology & neuroinflammation. vol 10. issue 2. 2023-01-24. PMID:36693760. to evaluate the effects of the coronavirus disease 2019 (covid-19) pandemic on the life of patients with neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated diseases (mogad). 2023-01-24 2023-08-14 Not clear
Anna A Shah, Andrew B Wolf, Anthony Declusin, Kyle Coleman, Ryan Kammeyer, Baber Khan, John R Corbo. Challenging Cases in Neuroimmunology. Seminars in neurology. vol 42. issue 6. 2023-01-23. PMID:36690027. by highlighting these challenging cases, we hope to instill fundamental points on the nuances of diagnosis and management for conditions including tumefactive multiple sclerosis, antibody-mediated encephalitis, antiphospholipid antibody syndrome, neuromyelitis optica, and myelin oligodendrocyte glycoprotein igg-associated disease. 2023-01-23 2023-08-14 Not clear
Mercedeh Farhat Sabet, Sumanta Barman, Mathias Beller, Sven G Meuth, Nico Melzer, Orhan Aktas, Norbert Goebels, Tim Prozorovsk. Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity. International journal of molecular sciences. vol 24. issue 1. 2023-01-08. PMID:36613687. anti-nmda receptor (nmdar) encephalitis is frequently associated with demyelinating disorders (e.g., multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein-associated disease (mogad)) with regard to clinical presentation, neuropathological and cerebrospinal fluid findings. 2023-01-08 2023-08-14 Not clear
Jorge Guzmán, Francisco Vera, Bernardita Soler, Reinaldo Uribe-San-Martin, Lorena García, Adolfo Del-Canto, Andrea Schlatter, Mauricio Salazar, Fernando Molt, Karla Ramirez, José Marín, Carolina Pelayo, Juan Pablo Cruz, Sebastián Bravo-Grau, Claudia Cárcamo, Ethel Ciamp. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases. Multiple sclerosis and related disorders. vol 69. 2022-12-15. PMID:36521387. anti-myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad) is an emerging disorder recognized as a clinical entity distinct from multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorders (nmosd-aqp4+), and its phenotypic spectrum continues to expand. 2022-12-15 2023-08-14 Not clear